SP

Supal Panilam Lakhatariya

Active Director Designated Partner DIN 07659180
DIN 07659180 First appointment Nov 2016 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 4 historical roles
Total affiliations 8 Since Nov 2016
Shareholding value •••• Premium profile

About Supal Panilam Lakhatariya

Data last updated:

Supal Panilam Lakhatariya has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 4 companies, including Supal Distributors Llp and Supal Medical & Wholesale Llp. Formerly with 4 companies, such as Dls Export Corporation Private Limited and Quealth Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹203 Cr; the largest is Mono Pharmacare Limited at ₹169 Cr (FY 2025).

DIN 07659180
Primary Designation Designated Partner
First Appointment 24 Nov 2016
Oldest Company Age 9 yrs
Largest company Mono Pharmacare Limited · ₹169 Cr (FY 2025)
Combined revenue ₹203 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mono Pharmacare Limited L24304GJ2022PLC136193
Director17 Oct 20222022₹169 Cr (FY 2025)Active
Supal Pharmacare Limited U47721GJ2023PLC142969
Director17 Jul 20232023₹33.91 Cr (FY 2024)Active
Fam & Fab Limited U20237GJ2024PLC157190
Director18 Dec 20242024–Active
Designated Partner24 Nov 20162016–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Oct 20212021–Strike Off
Director24 Dec 20202020₹15.73 Cr (FY 2024)Active
Designated Partner24 May 20172017–Converted And Dissolved
Stylemantraas Private Limited U36999GJ2022PTC132832
Director14 Jun 20222022–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Supal Distributors Llp
Supal Medical & Wholesale Llp
Stylemantraas Private Limited
Mono Pharmacare Limited
Premium access

Shareholding and investment profile for Supal Panilam Lakhatariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Supal Panilam Lakhatariya

Supal Panilam Lakhatariya has 9 years in corporate governance. Holds Designated Partner and Director roles. Currently with 4 companies, including Supal Distributors Llp and Supal Medical & Wholesale Llp. Formerly with 4 companies, such as Dls Export Corporation Private Limited and Quealth Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹203 Cr; the largest is Mono Pharmacare Limited at ₹169 Cr (FY 2025).

Supal Panilam Lakhatariya is associated with 4 companies as Designated Partner and Director, including Mono Pharmacare Limited (₹169 Cr), Supal Pharmacare Limited (₹33.91 Cr), Fam & Fab Limited.

Supal Panilam Lakhatariya has expertise in General Business.

Supal Panilam Lakhatariya has 9 years in corporate governance.

By reported revenue, the largest current company of Supal Panilam Lakhatariya is Mono Pharmacare Limited, with revenue of ₹169 Cr (FY 2025).

The 2 current companies of Supal Panilam Lakhatariya that report revenue have a combined latest revenue of ₹203 Cr.

Supal Panilam Lakhatariya currently holds positions at 4 companies: Mono Pharmacare Limited (₹169 Cr), Supal Pharmacare Limited (₹33.91 Cr), Fam & Fab Limited, Supal Distributors Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available